Complications of chickenpox in an immunocompetent boy;Complicaciones de la varicela en el niño inmunocompetente

Anales de Pediatria

Volumn 59, Issue SUPPL. 1, 2003, Pages 18-26

  Moraga Llop, F A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

BLEEDING; CELLULITIS; CHICKENPOX; COST BENEFIT ANALYSIS; DISEASE COURSE; ENCEPHALITIS; FASCIITIS; GANGRENE; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENT CELL; LETHALITY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; TOXIC SHOCK SYNDROME; VACCINATION;

EID: 0742301324     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Plotkin SA, Friedman HM, Starr SE. Vaccines against viruses of the herpes group. En: Root RK, Warren KS, Griffiss JM, editors. Immunization. London: Penguin, 1998; p. 65-92.
2. Moraga FA, Domínguez A, Roca J, Jané M, Torner N, Salleras L, et al. Paediatric complications of varicella requiring hospitalization. Vacunas Invest Pract 2000;1:106-11.
3. Riaza Gómez M, de la Torre Espí M, Mencía Bartolomés S, Molina Cabañero JC, Tamariz-Martes Moreno A. Complicaciones de la varicela en niños. An Esp Pediatr 1999;50:259-62.
4. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706-12.
5. Preblud SR. Varicella: Complications and Costs. Pediatrics 1986;78:728-35.
6. Guess HA, Broughton DD, Melton III LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986;78:723-7.
7. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J 2002;21:931-4.
8. Peterson CL, Mascola L, Chao SM, Lieberman JM, Arcinue EL, Blumberg DA, et al. Children hospitalized for varicella: a prevaccine review. J Pediatr 1996;129:529-36.
9. CDC. Prevention of varicella updated. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (No. RR-06):1-5.
10. Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr 1997;130:759-65.
11. Gil A, San-Martín M, Carrasco P, González A. Hospitalizaciones por varicela en Madrid durante el período 1995-1999. Vacunas Invest Pract 2002;3:99-102.
12. Jiménez R, Rivero A, Gil A. Descriptive study of spanish patients hospitalized due to varicella during 1998. 18th Annual Meeting of European Society for Paediatric Infectious Diseases (ESPID). Abstract Book, 2000-65.
13. Fornaro P, Gandini F, Marin M, Pedrazzi C, Piccoli P, Tognetti D, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr Infect Dis J 1999;18:414-9.
14. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
15. Seward JF. Update on varicella. Pediatr Infect Dis J 2001;20:619-21.
16. Salleras L, Pujals JM, Salleras M. Vacuna antivaricela-zoster. En: Salleras L, editor. Vacunaciones Preventivas. Principios y aplicaciones. Barcelona: Masson, 2003; p. 311-30.
17. Comité Asesor de Vacunas. Asociación Española de Pediatría. Manual de vacunas en pediatría. Madrid: Litofinter, 2001; p. 316-33.
18. Campins Martí M, Moraga Llop FA. ¿Es eficaz la vacuna de la varicela? Med Clin (Barc) 2002;119:571-3.
19. a ed. Philadelphia: WB Saunders, 1999; p. 475-507.
20. CDC. Evaluation of varicella reporting to the National Notificable Diseases surveillance system-United States, 1972-1997. MMWR 1999;48:55-8.
21. CDC. Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45 (No. RR-11):1-36.
22. Ruiz Contreras J, de Arístegui Fernández J, Bernácer Borja M, Sánchez de Toledo Codina J. Recomendaciones de uso de la vacuna antivaricela en niños inmunocomprometidos. An Esp Pediatr 1999;50:113-8.
23. Aristegui J, Calbo-Torrecillas F, Díez-Domingo J, González-Hachero J, Moraga F, Peña-Guitián, et al. Varicella epidemiology in Spain: prospective, multicenter study in children attending primary care centers. 19th Annual Meeting of European Society for Paediatric Infectious Diseases (ESPID). Abstract Book, 2001;58.
24. Díez-Domingo J, Arístegui J de, Calbo-Torrecillas F, Gonzâlez-Hachero J, Moraga Llop F, Peña-Guitián, et al. Epidemiología y coste de la varicela en niños atendidos en centros de salud de España. Vacunas Invest Pract 2001;2 (Supl 1):16-9.
25. Moraga-Llop FA, Gallart-Catalá A, Castillejo G. Complications of varicella requiring hospitalization. The 14th Annual Meeting of European Society for Paediatric Infectious Diseases (ESPID). Abstract Book, 1996;67.
26. Gil A, Oyagüez I, Carrasco P, González A. Epidemiology of primary varicella hospitalizations in Spain. Vaccine 2002;20:295-8.
27. Moraga Llop FA, Campins Martí M. Vacuna de la varicela. Una inmunización del niño y del adulto. Enferm Infec Microbiol Clin 2000;18:516-8.